Lou Ruvo Brain Institute

Recent papers from Lou Ruvo Brain Institute

1. The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuumScientific Reports · 2016
2. Pattern Discovery in Brain Imaging Genetics via SCCA Modeling with a Generic Non-convex PenaltyScientific Reports · 2017
3. Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia statesScientific Reports · 2018
4. KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s diseaseCivil War Book Review · 2021
5. Proximity to Water Pollutant Facilities and Risk of Incident Progressive Supranuclear PalsyNeurology · 2026
6. A revised visual grading scale of the cavum septi pellucidi in contact-collision sport athletes with repetitive head impactsCommunications Medicine · 2026
7. Alzheimer's diseaseThe Lancet · 2021
8. Cerebrospinal Fluid Over Plasma Links Analytes to Cognitive Decline in Older Adults at Risk for Alzheimer's DiseaseAnnals of Clinical and Translational Neurology · 2026
9. Regional ventricular enlargement as an in vivo biomarker of cumulative biomechanical neurodegeneration in former American football playersAlzheimer s & Dementia · 2026
10. Operationalizing Alzheimer's disease trials in the era of targeted therapiesAlzheimer s & Dementia · 2026
11. Centrally Acting Medications, Chronic Pain, and Orthopedic Surgical History Among Former American Football PlayersNeurology · 2026
12. Associations of Plasma GDF15, CRP, and IL-6 With Cognitive Trajectories in Patients With Frontotemporal Lobar DegenerationNeurology Open Access · 2026
13. Music-Based Interventions in DementiaCurrent Treatment Options in Neurology · 2026
14. Considerations in Alzheimer’s Disease in WomenCurrent Neurology and Neuroscience Reports · 2026
15. Plasma Phosphorylated Tau 217 in Participants at Risk for Chronic Traumatic EncephalopathyJAMA Network Open · 2026
16. Non-invasive Brain Stimulation for Parkinson’s Disease: Therapeutic Applications and Clinical PerspectivesJournal of Movement Disorders · 2026
17. Assessing Progression Independent of Relapse Activity in Multiple Sclerosis Using a Patient‐Reported Disability Measure and Self‐Administered Neuroperformance OutcomesAnnals of Neurology · 2026
18. Neuropathological study of the effects of aducanumab anti-Aβ immunotherapy on patients with Alzheimer’s diseaseActa Neuropathologica · 2026
19. Brain regional susceptibility to tauopathy in individuals at risk for chronic traumatic encephalopathyAlzheimer s & Dementia · 2026
20. Cognitive, biomarker, and neuroimaging indices associated with traumatic encephalopathy syndrome across two independent athlete cohortsAlzheimer s Research & Therapy · 2026